Loading...

ABEO ABEONA THERAPEUTICS INC Expansion Plans 8-K Filing

BN T

B

ABEONA THERAPEUTICS INC

(ABEO)

2026 8-K

Financial Results Released

Business Update

Quarterly Financial Results

Financial Results Report

Debt-Equity Swaps

Asset Acquisitions

Asset Acquisitions

New Product Launches

Financial Results

Share Increase Approval

Q3 2024 Results

FDA Application Resubmission

Board Appointments

Q2 2024 Results

Amendment of Bylaws

Financial Results

Financial Update

Equity Incentive Plan Approval

Financial Results Press Rel...

FDA Accepts and Grants Prio...

Earnings Report

Change in Accounting Firm

Earnings Reports

Rights Offerings

Annual Meeting of Stockholders

Earnings Report

Board Restructuring

Earnings Report

Regulation FD Disclosure

External Links:

On March 9, 2026, Abeona Therapeutics Inc. announced its continuing progress in the commercial launch of ZEVASKYN, highlighting positive momentum in its business operations. The filing confirms the significance of this development as part of the company’s growth strategy.

AI Assistant

ABEONA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.